| scholarly article | Q13442814 |
| P50 | author | Andreia V Pinho | Q56482259 |
| Nils Eling | Q57496148 | ||
| Simone Camargo | Q63981424 | ||
| Ilse Rooman | Q83181310 | ||
| Andrew Biankin | Q38802580 | ||
| P2093 | author name string | Amanda Mawson | |
| Jianmin Wu | |||
| Anthony Gill | |||
| Marc Giry-Laterriere | |||
| Mehreen Arshi | |||
| Evelyne Kuster | |||
| Max Warmerdam | |||
| Triyana Lie | |||
| P2860 | cites work | Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes | Q24595981 |
| Diverse roles of SIRT1 in cancer biology and lipid metabolism | Q26997827 | ||
| Pancreas-Specific Sirt1-Deficiency in Mice Compromises Beta-Cell Function without Development of Hyperglycemia | Q27305957 | ||
| High SIRT1 expression is a negative prognosticator in pancreatic ductal adenocarcinoma | Q27852569 | ||
| Sirtuins in mammals: insights into their biological function | Q29615248 | ||
| Epigenetic protein families: a new frontier for drug discovery | Q29616621 | ||
| Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice | Q29617045 | ||
| Metabolic reprogramming: a cancer hallmark even warburg did not anticipate | Q29617612 | ||
| Developmental defects and p53 hyperacetylation in Sir2 homolog (SIRT1)-deficient mice | Q29619786 | ||
| Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse | Q29620396 | ||
| Enterocyte-specific inactivation of SIRT1 reduces tumor load in the APC(+/min) mouse model | Q31120854 | ||
| SIRT1 promotes thyroid carcinogenesis driven by PTEN deficiency. | Q39276801 | ||
| PGC1α promotes tumor growth by inducing gene expression programs supporting lipogenesis. | Q39474407 | ||
| SIRT1 RNAi knockdown induces apoptosis and senescence, inhibits invasion and enhances chemosensitivity in pancreatic cancer cells | Q39523760 | ||
| Oncogenic Kras is required for both the initiation and maintenance of pancreatic cancer in mice | Q40679145 | ||
| c-MYC and SIRT1 locked in a vicious cycle | Q42548615 | ||
| Expression of S100A2 calcium-binding protein predicts response to pancreatectomy for pancreatic cancer | Q47987813 | ||
| SOX9 regulates ERBB signalling in pancreatic cancer development. | Q53229089 | ||
| Genome-wide DNA methylation patterns in pancreatic ductal adenocarcinoma reveal epigenetic deregulation of SLIT-ROBO, ITGA2 and MET signaling. | Q53242589 | ||
| Sirtuin-1 regulates acinar-to-ductal metaplasia and supports cancer cell viability in pancreatic cancer. | Q53258776 | ||
| Deleted in breast cancer-1 regulates SIRT1 activity and contributes to high-fat diet-induced liver steatosis in mice | Q33604863 | ||
| How does SIRT1 affect metabolism, senescence and cancer? | Q33802917 | ||
| The complex landscape of pancreatic cancer metabolism | Q33827703 | ||
| Hexokinase II inhibitor, 3-BrPA induced autophagy by stimulating ROS formation in human breast cancer cells | Q33880100 | ||
| Loss of Sirt1 function improves intestinal anti-bacterial defense and protects from colitis-induced colorectal cancer | Q33890004 | ||
| Adiponectin promotes pancreatic cancer progression by inhibiting apoptosis via the activation of AMPK/Sirt1/PGC-1α signaling | Q34104012 | ||
| Acetylation targets the M2 isoform of pyruvate kinase for degradation through chaperone-mediated autophagy and promotes tumor growth. | Q34195003 | ||
| An exploratory double-blind, randomized clinical trial with selisistat, a SirT1 inhibitor, in patients with Huntington's disease | Q35135962 | ||
| DBC1 functions as a tumor suppressor by regulating p53 stability | Q35152261 | ||
| Oncogene ablation-resistant pancreatic cancer cells depend on mitochondrial function | Q35223050 | ||
| SirT1 modulates the estrogen-insulin-like growth factor-1 signaling for postnatal development of mammary gland in mice. | Q35749349 | ||
| Activation of p53 by SIRT1 inhibition enhances elimination of CML leukemia stem cells in combination with imatinib | Q35774432 | ||
| Therapeutic Targeting of the Warburg Effect in Pancreatic Cancer Relies on an Absence of p53 Function | Q35958099 | ||
| Metabolite profiling stratifies pancreatic ductal adenocarcinomas into subtypes with distinct sensitivities to metabolic inhibitors | Q35961180 | ||
| Role of deleted in breast cancer 1 (DBC1) protein in SIRT1 deacetylase activation induced by protein kinase A and AMP-activated protein kinase. | Q36078757 | ||
| Oncogenic Kras maintains pancreatic tumors through regulation of anabolic glucose metabolism | Q36319414 | ||
| Janus-faced role of SIRT1 in tumorigenesis | Q36403645 | ||
| Glucose metabolism as a target of histone deacetylase inhibitors. | Q37125470 | ||
| SIRT1: Regulator of p53 Deacetylation | Q37150526 | ||
| The emerging and diverse roles of sirtuins in cancer: a clinical perspective | Q37231067 | ||
| PGC-1alpha, SIRT1 and AMPK, an energy sensing network that controls energy expenditure | Q37412140 | ||
| SIRT1 and other sirtuins in metabolism | Q37619655 | ||
| The diversity of histone versus nonhistone sirtuin substrates. | Q38135829 | ||
| KRAS: feeding pancreatic cancer proliferation | Q38175666 | ||
| SIRT1 metabolic actions: Integrating recent advances from mouse models | Q38190964 | ||
| SIRT1 deacetylates and stabilizes hypoxia-inducible factor-1α (HIF-1α) via direct interactions during hypoxia | Q38298978 | ||
| Pancreatic cancer: from state-of-the-art treatments to promising novel therapies | Q38396634 | ||
| Emerging Drug Target In Pancreatic Cancer: Placing Sirtuin 1 on the Canvas. | Q38568551 | ||
| K-Ras promotes the non-small lung cancer cells survival by cooperating with sirtuin 1 and p27 under ROS stimulation | Q38884503 | ||
| Tumor suppressor p53 negatively regulates glycolysis stimulated by hypoxia through its target RRAD | Q38966981 | ||
| Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States | Q39190004 | ||
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P433 | issue | 46 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 74768-74778 | |
| P577 | publication date | 2016-08-02 | |
| P1433 | published in | Oncotarget | Q1573155 |
| P1476 | title | Sirtuin 1 stimulates the proliferation and the expression of glycolysis genes in pancreatic neoplastic lesions | |
| P478 | volume | 7 |
| Q60919715 | Glucose and Lactate Transport in Pancreatic Cancer: Glycolytic Metabolism Revisited |
| Q92445902 | Granulosa-Lutein Cell Sirtuin Gene Expression Profiles Differ between Normal Donors and Infertile Women |
| Q90207146 | KRAS-Driven Metabolic Rewiring Reveals Novel Actionable Targets in Cancer |
| Q92731070 | Sorafenib-Induced Apoptosis in Hepatocellular Carcinoma Is Reversed by SIRT1 |
| Q45419184 | The Glycolytic Switch in Tumors: How Many Players Are Involved? |
Search more.